Status:
COMPLETED
Loss to Follow-up in PDR Patients
Lead Sponsor:
Assiut University
Conditions:
Diabetic Retinopathy
Eligibility:
All Genders
40-70 years
Brief Summary
This study determined the clinical impact and causes of loss to follow-up (LTFU) from the patients' perspective in individuals with proliferative diabetic retinopathy (PDR) who received panretinal pho...
Eligibility Criteria
Inclusion
- included treatment-naïve patients who had developed PDR in one eye with a best corrected visual acuity (BCVA) ranging from 20/22 to 20/69, as determined by the Snellen equivalent. Patients were allocated to receive PRP, IVIs of anti-VEGF, or a combination of both procedures.
Exclusion
- patients receiving follow-up ophthalmic care for their PDR with or without interventions at any other medical care provider during the observation period, as declared by the patients at any follow up visit.
- patients LTFU who did not resume follow-up until the end of the observation period.
- patients needing PPV at first presentation or having additional retinal pathology. 4) patients receiving their treatment procedure during December 2017 or having vitreous hemorrhage that failed to clear up by June 2018 but still ineligible candidates for PPV.
Key Trial Info
Start Date :
May 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 25 2018
Estimated Enrollment :
467 Patients enrolled
Trial Details
Trial ID
NCT04018326
Start Date
May 1 2013
End Date
December 25 2018
Last Update
July 12 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.